Find Haemophilus Influenzae Type B manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Australia

Australia

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

FDF Dossiers

read-more
read-more

01

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Sweden

Haemophilus influenzae type B polysaccharide

Brand Name : Act-HIB

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

02

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Schedule D

Registration Country : Canada

HAEMOPHILUS INFLUENZAE TYPE B-PRP

Brand Name : ACT-HIB

Dosage Form : KIT

Dosage Strength : 10MCG/0.5ML

Packaging : 5X1VIAL - 5X0.5ML AMP

Approval Date :

Application Number : 1959034

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

03

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Schedule D

Registration Country : Canada

HAEMOPHILUS INFLUENZAE TYPE B-PRP

Brand Name : PENTACEL

Dosage Form : SUSPENSION

Dosage Strength : 10MCG/0.5ML

Packaging :

Approval Date :

Application Number : 2534797

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

04

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Haemophilus influenzae type b

Brand Name : Pentaxim ®

Dosage Form : INJ

Dosage Strength : 10mcg

Packaging : 0.5X1IU

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

05

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Haemophilus influenzae type b polysaccharide, conjugated to tetanus protein [tetanus protein: 22 – 36  µg]

Brand Name : Hexaxim ®

Dosage Form : INJ

Dosage Strength : 12µg/0.5ml

Packaging : 0.5X1IU/5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

06

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Haemophilus influenzae type b

Brand Name : Hexaxim ®

Dosage Form : INJ

Dosage Strength : 12µg/0.5ml

Packaging : 0.5X10IU/0.5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

07

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Hemophilus influenzae B, combinations with toxoids

Brand Name : Act-HIB

Dosage Form : VAC

Dosage Strength : 10mcg

Packaging : 1X1mcg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

08

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Hemophilus influenzae B, combinations with toxoids

Brand Name : CombAct-HIB

Dosage Form : VAC

Dosage Strength : 10mcg

Packaging : 1X1mcg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

09

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Hemophilus influenzae B, combinations with toxoids

Brand Name : CombAct-HIB

Dosage Form : VAC

Dosage Strength : 10mcg

Packaging : 1X1mcg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

10

AstraZeneca

United Kingdom
Arvo
Not Confirmed
arrow

AstraZeneca

United Kingdom
arrow
Arvo
Not Confirmed

INFLUENZA VIRUS TYPE B (YAMAGATA)

Brand Name : FLUMIST QUADRIVALENT

Dosage Form : SPRAY

Dosage Strength : 32000000FFU/0.2ML

Packaging :

Approval Date :

Application Number : 2426544

Regulatory Info : Schedule D

Registration Country : Canada

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Sweden

Haemophilus influenzae type B polysaccharide

Brand Name : Act-HIB

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

02

GlaxoSmithKline AB

United Kingdom
Arvo
Not Confirmed
arrow

GlaxoSmithKline AB

United Kingdom
arrow
Arvo
Not Confirmed

Haemophilus influenzae typ B polysackarid

Brand Name : Hiberix

Dosage Form : PULVER OCH VÄTSKA TILL INJEKTIONSVÄTSKA

Dosage Strength : --

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Schedule D

Registration Country : Canada

HAEMOPHILUS INFLUENZAE TYPE B-PRP

Brand Name : ACT-HIB

Dosage Form : KIT

Dosage Strength : 10MCG/0.5ML

Packaging : 5X1VIAL - 5X0.5ML AMP

Approval Date :

Application Number : 1959034

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Schedule D

Registration Country : Canada

HAEMOPHILUS INFLUENZAE TYPE B-PRP

Brand Name : PENTACEL

Dosage Form : SUSPENSION

Dosage Strength : 10MCG/0.5ML

Packaging :

Approval Date :

Application Number : 2534797

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

03

ASTRAZENECA CANADA INC

United Kingdom
Arvo
Not Confirmed
arrow

ASTRAZENECA CANADA INC

United Kingdom
arrow
Arvo
Not Confirmed

INFLUENZA VIRUS TYPE B (VICTORIA)

Brand Name : FLUMIST QUADRIVALENT

Dosage Form : SPRAY

Dosage Strength : 32000000FFU/0.2ML

Packaging :

Approval Date :

Application Number : 2426544

Regulatory Info : Schedule D

Registration Country : Canada

blank

04

ASTRAZENECA CANADA INC

United Kingdom
Arvo
Not Confirmed
arrow

ASTRAZENECA CANADA INC

United Kingdom
arrow
Arvo
Not Confirmed

INFLUENZA VIRUS TYPE B (YAMAGATA)

Brand Name : FLUMIST QUADRIVALENT

Dosage Form : SPRAY

Dosage Strength : 32000000FFU/0.2ML

Packaging :

Approval Date :

Application Number : 2426544

Regulatory Info : Schedule D

Registration Country : Canada

blank

05

GLAXOSMITHKLINE INC

United Kingdom
Arvo
Not Confirmed
arrow

GLAXOSMITHKLINE INC

United Kingdom
arrow
Arvo
Not Confirmed

HAEMOPHILUS INFLUENZAE TYPE B-PRP

Brand Name : INFANRIX HEXA

Dosage Form : SUSPENSION

Dosage Strength : 10MCG/0.5ML

Packaging : 10X0.5ML

Approval Date :

Application Number : 2253852

Regulatory Info : Schedule D

Registration Country : Canada

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Haemophilus influenzae type b

Brand Name : Pentaxim ®

Dosage Form : INJ

Dosage Strength : 10mcg

Packaging : 0.5X1IU

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Haemophilus influenzae type b polysaccharide, conjugated to tetanus protein [tetanus protein: 22 – 36  µg]

Brand Name : Hexaxim ®

Dosage Form : INJ

Dosage Strength : 12µg/0.5ml

Packaging : 0.5X1IU/5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Haemophilus influenzae type b

Brand Name : Hexaxim ®

Dosage Form : INJ

Dosage Strength : 12µg/0.5ml

Packaging : 0.5X10IU/0.5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Hemophilus influenzae B, combinations with toxoids

Brand Name : Act-HIB

Dosage Form : VAC

Dosage Strength : 10mcg

Packaging : 1X1mcg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Hemophilus influenzae B, combinations with toxoids

Brand Name : CombAct-HIB

Dosage Form : VAC

Dosage Strength : 10mcg

Packaging : 1X1mcg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Hemophilus influenzae B, combinations with toxoids

Brand Name : CombAct-HIB

Dosage Form : VAC

Dosage Strength : 10mcg

Packaging : 1X1mcg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Haemophilus Influenza Type B: PRP

Brand Name : Rotarix Oral Vaccine

Dosage Form : POW

Dosage Strength : 10ug/0.5ml

Packaging : 1X1CCID 50/dose

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

08

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Haemophilus Influenza Type B: T

Brand Name : Rotarix Oral Vaccine

Dosage Form : POW

Dosage Strength : 40ug/0.5ml

Packaging : 1X1CCID 50/dose

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

09

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Hemophilus influenzae b

Brand Name : Hiberix

Dosage Form : VAC

Dosage Strength : 10mcg/0.5ml

Packaging : 3X1mcg/0.5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Haemophilus Influenzae Type b

Brand Name :

Dosage Form : Vaccine

Dosage Strength :

Packaging : PFS/Vial

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

01

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Haemophilus Influenzae Type b

Dosage : Vaccine

Dosage Strength :

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty